Our Product
CMM® Sensor
Indigo’s continuous multi-metabolite monitoring (CMM®) sensor is a small spectrometer-on-a-chip to monitor multiple metabolites in-vivo simultaneously and continuously.
The inert, miniature integrated silicon photonics spectrometer chip measures the absorption of light in the interstitial fluid to quantify the concentration of multiple metabolites simultaneously without the use of enzymes or fluorophores.
Once implanted under the skin, the CMM®sensor is invisible to the naked eye and will connect securely and wirelessly to mobile devices via Bluetooth to share the concentration profiles of the user’s metabolites with their caregivers and family members. A rechargeable sensor battery powers the measurements.
It is expected that the sensor will be replaced annually with the potential to extend this to two years in the future and not require calibration. First in human studies have successfully demonstrated proof of concept with promising accuracy.
Disclaimer: NOT FDA cleared. NOT CE -marked. Product under clinical investigation. Product not available on the market, not for sale.
Technology
Indigo uses ground-breaking nanophotonics technology to analyze levels of metabolites via an on-chip miniature spectrometer. The inert, miniature spectrometer chip measures the absorption of light in the individual’s interstitial fluid to quantify the concentration of multiple metabolites simultaneously without the use of enzymes or fluorophores.
Indigo’s CMM® sensor is protected by many international patent families.
Indigo has received ISO 13485 certification from TÜV Süd for the Design and Development of Biomarker Sensing Devices and Services.
Our implantable, Continuous Multi-metabolite Monitor (CMM®) will revolutionize management of chronic disease.
